Skip to Content
Upcoming Webinar

Outpatient Step-Up Dosing of Bispecific T-Cell Engagers

Date: November 14, 2025 | 2:00 PM
When: Friday, November 14 | 2 p.m. EST
Presenters:
Tara Graff, DO, MS | Mission Cancer + Blood

As bispecific T-cell engagers (BTCEs) move from clinical trials into everyday oncology practice, more centers are adopting outpatient step-up dosing — a shift that offers patients greater access but also introduces new safety and coordination challenges.

In this session, Dr. Tara Graff shares how oncology teams can confidently transition step-up dosing to the outpatient setting with clear protocols and monitoring strategies.

Learn how to:

  • Determine patient eligibility and readiness for outpatient dosing
  • Structure and adjust step-up dosing schedules
  • Monitor for cytokine release and early toxicities
  • Build coordination between clinic and infusion staff to support safety

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.